Biocartis Group NV 2020 SR
The report details Biocartis' sustainability efforts in 2020, focusing on its Idylla platform and its role in personalized medicine. Key highlights include contributions to seven UN Sustainable Development Goals, the launch of a pandemic test menu for COVID-19 and sepsis, and maintaining a balanced gender diversity of 49% women. The company also emphasized data privacy, information security, and ethical business practices through its Code of Conduct. Environmental initiatives focused on waste management optimization and monitoring energy and water consumption.
Company: Biocartis Group NV
Sector: Manufacturing
Country: Belgium
Year: 2020
Type: SR
Pages: 88
Back to company
Biocartis Group NV
Non-Financial Report
The report details Biocartis' sustainability efforts in 2020, focusing on its Idylla platform and its role in personalized medicine. Key highlights include contributions to seven UN Sustainable Development Goals, the launch of a pandemic test menu for COVID-19 and sepsis, and maintaining a balanced gender diversity of 49% women. The company also emphasized data privacy, information security, and ethical business practices through its Code of Conduct. Environmental initiatives focused on waste management optimization and monitoring energy and water consumption.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Apr 1, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Workplace Fatalities
Employees